Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease DOI Creative Commons
Zihao Wang, Zhan Zhang, Peishan Li

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Dec. 28, 2024

Parkinson's disease (PD) is the second most common age-related neurodegenerative after Alzheimer's disease. Despite numerous studies, specific factors remain unidentified. This study employed a multi-omics approach to investigate link between PD and aging. We integrated blood gene expression profiles, quantitative trait loci, genome-wide association predictive models, conducted clinical validation.By analyzing datasets, total of 953 differentially expressed genes (DEGs) 10 intersecting aging (ADEGs) were identified. Enrichment analysis revealed that regulatory pathways these ADEGs involve classical Wnt signaling pathway, endoplasmic reticulum stress, neuronal apoptosis. Mendelian randomization (MR) showed MAP3K5 significantly reduces risk PD. Multivariate regression identified MXD1, CREB1, SIRT3 as key diagnostic constructed model aid decision-making. Enzyme-linked immunosorbent assay experiments validated levels in serum patients.This utilized identify their mechanisms PD, leading establishment model. The resource accessible at this link: https://yunhaihupo.shinyapps.io/DynNomapp . web application can be used standalone explore changes transcription profiles relationship aspects, generating new research hypotheses.

Language: Английский

Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis DOI Creative Commons
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2024, Volume and Issue: 30(5)

Published: May 1, 2024

Parkinson's disease (PD) is a degenerative neurological condition marked by the gradual loss of dopaminergic neurons in substantia nigra pars compacta. The precise etiology PD remains unclear, but emerging evidence suggests significant role for disrupted autophagy-a crucial cellular process maintaining protein and organelle integrity.

Language: Английский

Citations

18

Exosomal ncRNAs in liquid biopsies for lung cancer DOI
Md Sadique Hussain, Gaurav Gupta, Nehmat Ghaboura

et al.

Clinica Chimica Acta, Journal Year: 2024, Volume and Issue: 565, P. 119983 - 119983

Published: Oct. 3, 2024

Language: Английский

Citations

15

Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer DOI
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 262, P. 155570 - 155570

Published: Aug. 29, 2024

Language: Английский

Citations

10

MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies DOI

Dongying Zheng,

Jibing Chween

Neuroscience, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

1

Identification of ferroptosis-related LncRNAs as potential targets for improving immunotherapy in glioblastoma DOI
Zhaochen Wang, Xiao Jin,

Xiaoli Yong

et al.

Computer Methods in Biomechanics & Biomedical Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 13

Published: Jan. 1, 2025

The effect of ferroptosis-related long non-coding RNAs (lncRNAs) in predicting immunotherapy response to glioblastoma (GBM) remains obscure. This study established a 11-lncRNAs prognostic signature. Differential gene expression analysis, univariate and multivariate Cox regression analyses the least absolute shrinkage selection operator (LASSO) algorithm were used identify genes establish nomogram model risk score. Kaplan-Meier survival plots receiver operating characteristic (ROC) curve analysis evaluate accuracy TCGA-GBM cohort. To verify these signatures, we analyzed levels three lncRNAs (AGAP2-AS1, OSMR-AS1, UNC5B-AS1) LN229 U87 cells. ROC showed that area under (AUC) this signature is 0.814, suggesting it has promising performance on GBM prediction. rate patients high-risk group was significantly lower than low-risk group, prediction superior conventional clinicopathological factors. Further qRT-PCR experiment also confirmed our lncRNA signatures. These might be therapeutic targets for glioblastoma, targeting can improve efficacy immunotherapy, especially immune checkpoint inhibitors. Mechanistically, findings attribute N6-methyladenosine (m6A) mRNA modification lncRNAs.

Language: Английский

Citations

0

Characterization and neurotherapeutic evaluation of venom polypeptides identified from Vespa magnifica: The role of Mastoparan-M in Parkinson's disease intervention DOI
Chaojie Liu, Xiaoyu Li,

Mingran Chen

et al.

Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119481 - 119481

Published: Feb. 1, 2025

Language: Английский

Citations

0

Cerebellar Pathology in Forensic and Clinical Neuroscience DOI
Azhagu Madhavan Sivalingam,

Darshitha D Sureshkumar

Ageing Research Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 102697 - 102697

Published: Feb. 1, 2025

Language: Английский

Citations

0

piRNAs in leukemogenesis: Mechanisms, biomarkers, and therapeutic implications DOI
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal

et al.

Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: unknown, P. 120220 - 120220

Published: March 1, 2025

Language: Английский

Citations

0

The Critical Role of GLP-1 Signaling Pathways in the Pathology of Parkinson's Disease and Diabetes DOI
Jinhao Chen, Xiang Dong,

Yi-Chen Lin

et al.

Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155985 - 155985

Published: April 1, 2025

Language: Английский

Citations

0

Advances in Understanding Biomarkers and Treating Neurological Diseases -Role of the Cerebellar Dysfunction and Emerging Therapies DOI
Azhagu Madhavan Sivalingam

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: unknown, P. 102519 - 102519

Published: Sept. 1, 2024

Language: Английский

Citations

3